| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $1 ) |
| | 2024 | 2023 | COHEN VETERANS BIOSCIENCE INC | 535 8TH AVE FL 12 | NEW YORK | NY | 10018-2530 | NEW YORK | USA | R01CA278819 | dMRI-guided pre-operative planning for supra-total resection of high-gradegliomas | 003 | 2 | NIH | 9/18/2024 | -$539,600 |
| | 2024 | 2023 | COHEN VETERANS BIOSCIENCE INC | 535 8TH AVE FL 12 | NEW YORK | NY | 10018-2530 | NEW YORK | USA | R01CA278819 | dMRI-guided pre-operative planning for supra-total resection of high-gradegliomas | 001 | 2 | NIH | 3/28/2024 | $539,601 |
|
| Issue Date FY: 2023 ( Subtotal = $0 ) |
| | 2023 | 2021 | COHEN VETERANS BIOSCIENCE INC | 535 8TH AVE | NEW YORK | NY | 10018-2530 | NEW YORK | USA | R25GM133017 | Addressing Sex as a Biological Variable in Preclinical Pharmacology and Neuroscience Research: Accounting for Neglected Factors and Applying Practical Solutions to Enhance Rigor and Reproducibility | 000 | 3 | NIH | 1/10/2023 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $14,287 ) |
| | 2021 | 2021 | COHEN VETERANS BIOSCIENCE, INC. | 535 8TH AVE FL 12 | NEW YORK | NY | 10018-2530 | NEW YORK | USA | R25GM133017 | Addressing Sex as a Biological Variable in Preclinical Pharmacology and Neuroscience Research: Accounting for Neglected Factors and Applying Practical Solutions to Enhance Rigor and Reproducibility | 000 | 3 | NIH | 7/12/2021 | $7,324 |
| | 2021 | 2021 | COHEN VETERANS BIOSCIENCE, INC. | 535 8TH AVE FL 12 | NEW YORK | NY | 10018-2530 | NEW YORK | USA | R25GM133017 | Addressing Sex as a Biological Variable in Preclinical Pharmacology and Neuroscience Research: Accounting for Neglected Factors and Applying Practical Solutions to Enhance Rigor and Reproducibility | 000 | 3 | NIH | 7/12/2021 | $6,963 |
|
| Issue Date FY: 2020 ( Subtotal = $125,235 ) |
| | 2020 | 2020 | COHEN VETERANS BIOSCIENCE, INC. | 1 BROADWAY 14TH FL | CAMBRIDGE | MA | 02142-1187 | MIDDLESEX | USA | R25GM133017 | Addressing Sex as a Biological Variable in Preclinical Pharmacology and Neuroscience Research: Accounting for Neglected Factors and Applying Practical Solutions to Enhance Rigor and Reproducibility | 001 | 2 | NIH | 8/25/2020 | -$62,795 |
| | 2020 | 2020 | COHEN VETERANS BIOSCIENCE, INC. | 1 BROADWAY 14TH FL | CAMBRIDGE | MA | 02142-1187 | MIDDLESEX | USA | R25GM133017 | Addressing Sex as a Biological Variable in Preclinical Pharmacology and Neuroscience Research: Accounting for Neglected Factors and Applying Practical Solutions to Enhance Rigor and Reproducibility | 000 | 2 | NIH | 6/18/2020 | $125,235 |
| | 2020 | 2020 | COHEN VETERANS BIOSCIENCE, INC. | 1 BROADWAY 14TH FL | CAMBRIDGE | MA | 02142-1187 | MIDDLESEX | USA | R25GM133017 | Addressing Sex as a Biological Variable in Preclinical Pharmacology and Neuroscience Research: Accounting for Neglected Factors and Applying Practical Solutions to Enhance Rigor and Reproducibility | 001 | 2 | NIH | 8/25/2020 | $62,795 |
|
| Issue Date FY: 2019 ( Subtotal = $121,825 ) |
| | 2019 | 2019 | COHEN VETERANS BIOSCIENCE, INC. | 1 BROADWAY 14TH FL | CAMBRIDGE | MA | 02142-1187 | MIDDLESEX | USA | R25GM133017 | Addressing Sex as a Biological Variable in Preclinical Pharmacology and Neuroscience Research: Accounting for Neglected Factors and Applying Practical Solutions to Enhance Rigor and Reproducibility | 000 | 1 | NIH | 7/29/2019 | $60,912 |
| | 2019 | 2019 | COHEN VETERANS BIOSCIENCE, INC. | 1 BROADWAY 14TH FL | CAMBRIDGE | MA | 02142-1187 | MIDDLESEX | USA | R25GM133017 | Addressing Sex as a Biological Variable in Preclinical Pharmacology and Neuroscience Research: Accounting for Neglected Factors and Applying Practical Solutions to Enhance Rigor and Reproducibility | 000 | 1 | NIH | 7/29/2019 | $60,913 |
|
|
